M3, Inc.

M3, Inc.

MTHRF

$10.36

Updated: 23/09/2026, 04:36:36

Market Cap
$6.92B
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
JP
Stock valuation chart
One-year closing share-price history for MTHRF
Company Profile

M3, Inc., a Japanese corporation established in 2000 and headquartered in Tokyo, primarily delivers internet-based services to physicians and other healthcare professionals. Its operations are strategically divided into five key segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The company manages an extensive portfolio of digital platforms tailored for medical practitioners. This includes m3.com, an exclusive online portal offering healthcare information, and MR-kun, which enables member doctors to continuously access updates and content from the m3com system. QOL-kun further supports members with non-medical, life-enhancement information. For the general public, M3 operates AskDoctors, where registered medical experts address health and illness inquiries. On an international scale, the company provides MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., which assists pharmaceutical companies and hosts drug information databases across France, Germany, and Spain. Additionally, M3 supports career development for doctors and pharmacists through its m3com CAREER service. Beyond these online platforms, M3, Inc. engages in a wide array of activities within the medical and pharmaceutical sectors. This encompasses sales and marketing initiatives for pharmaceuticals and medical devices, along with the development, distribution, and maintenance of electronic medical records and equipment for healthcare institutions. The company also conducts surveys for medical professionals, offers online sales and marketing support to pharmaceutical firms, provides management consulting and assistance to medical facilities, operates home-visit nursing services, delivers human resources solutions for the healthcare industry, and manages clinical trial facilities. Originally incorporated as So-netM3, Inc., the company officially rebranded to M3, Inc. in January 2010.

USD
OTC
CEO: Itaru Tanimura
Employees: 17,010
https://corporate.m3.com
Asset Summaries
Latest generated summaries for MTHRF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for MTHRF.
Share price
$10.36
Market cap
$6.92B
Exchange
OTC
Currency
USD
CEO
Itaru Tanimura
Employees
17,010
IPO date
09/09/2014
Beta
0.475
Last dividend
$0.00
Day range
$10.02 – $10.36
52-week range
$8.55 – $15.25
1-day performance
0.00%
1-year performance
21.18%
Current drawdown (1Y)
-32.05%
CIK
N/A
CUSIP
N/A
ISIN
JP3435750009
Created
07/12/2025, 05:20:58
Last update
23/09/2026, 04:36:36

Track M3, Inc. with an AI analyst

See which prediction-market events move MTHRF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to MTHRF from your Railway `news_articles` table.

No news found for this symbol.